A. Deluca

Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2− Metastatic Breast Cancer Treated with Abemaciclib

K. Saverno, J. Beyrer, H. Abedtash, 2021, Drugs - Real World Outcomes.

Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.

Esposito, M. Loda, M. Pagano, 1997, Cancer research.

Development of a Prognostic Factor Index Among Women With HR+/HER2- Metastatic Breast Cancer in a Community Oncology Setting.

A. Gilligan, K. Saverno, L. Schwartzberg, 2021, Clinical breast cancer.